Top News
The White House proposes a crackdown on telehealth-related prescribing of some medications when the COVID public health emergency ends on May 11.
Providers would be required to conduct at least one in-person visit…
The catastrophic impact of the Covid-19 pandemic – from both a public health and an economic perspective – will stay with us for a long, long time to come. We will likely refer to…
Continue Reading
A Fulcrum Therapeutics clinical trial testing a potential sickle cell disease drug has been paused by the FDA. With the clinical hold on the early-stage study, Fulcrum becomes the fourth company with a stalled…
Continue Reading
Ovia Health, a digital health platform for family care, is expanding its platform to include menopause-focused offerings.Users will be able to track symptoms and access educational content, treatment options and tips on communicating with…
Continue Reading
While most people don’t choose a healthcare career to drive profits, many soon realize that it’s impossible to support high-quality care without having a clear understanding of the financial realities of the business. This…
Continue Reading
Stuart Hanson, CEO of Avaneer HealthInteroperability in the U.S. healthcare system has been an ongoing challenge. While there are several industry initiatives that are going to advance the industry and make incremental progress toward…
Continue Reading
Hemophilia A patients manage the chronic disorder with infusions administered as frequently as every two to three days. The FDA has approved a Sanofi drug designed to last longer in the body, giving patients…
Continue Reading
Top News
Teladoc Health reports Q4 results: revenue up 15%, EPS –$0.23 versus –$0.07, beating revenue expectations but falling short on earnings.
The company reported a staggering $13.7 billion loss for FY 2022, much of…
The vast majority of the critically essential secrets in biology are hidden from researchers. The human microbiome is now considered a human organ, yet the word “microbiome” was not in the research lexicon as…
Continue Reading
AbbVie turned to Capsida Biotherapeutics two years ago for help delivering gene therapies into the brain. That partnership is ongoing, but the pharmaceutical giant now wants to leverage its partner’s technology for delivery of…
Continue Reading
